100% agree with what you wrote. Again, the Ipix creative writing team had to dig deep to find anything just anything to say to offset end of October (Lemoncat has suggested this timeline for the last 45 days). So, instead of military conference data or an update on Kevetrin or that IBD trial or oral Mucositis trial, or the ceo reducing his salary etc they elect a live wire topic of compassionate use requests which has zero upside to PR and only downside risk.
But this is Ipix. And as you said yesterday, a not so distant cousin to NNVC. Hype and hope and generating excitement for the peanut gallery is all that matters.